Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Nephrol Dial Transplant

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    December 2017
  1. AGARWAL R
    Mechanisms and mediators of hypertension induced by erythropoietin and related molecules.
    Nephrol Dial Transplant. 2017 Dec 8. pii: 4712017. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  2. BIRNIE K, Caskey F, Ben-Shlomo Y, Sterne JA, et al
    Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.
    Nephrol Dial Transplant. 2017;32:692-698.
    PubMed     Text format     Abstract available


    March 2017
  3. CHEN N, Qian J, Chen J, Yu X, et al
    Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
    Nephrol Dial Transplant. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. CAVERO T, Rabasco C, Lopez A, Roman E, et al
    Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32:466-474.
    PubMed     Text format     Abstract available


    February 2017
  5. FLISER D, Dellanna F, Koch M, Wiggenhauser A, et al
    Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
    Nephrol Dial Transplant. 2017;32:279-287.
    PubMed     Text format    


    January 2017
  6. VAN DEN BRAND JA, Verhave JC, Adang EM, Wetzels JF, et al
    Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.
    Nephrol Dial Transplant. 2017;32.
    PubMed     Text format     Abstract available


    September 2016
  7. EVANS M, Carrero JJ, Bellocco R, Barany P, et al
    Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


  8. MICHELS WM, Jaar BG, Ephraim PL, Liu Y, et al
    Intravenous iron administration strategies and anemia management in hemodialysis patients.
    Nephrol Dial Transplant. 2016.
    PubMed     Text format     Abstract available


    October 2015
  9. OKPARAVERO A, Foster MC, Tighiouart H, Gudnason V, et al
    Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


    September 2015
  10. BHANDARI S, Kalra PA, Kothari J, Ambuhl PM, et al
    A randomized, open-label trial of iron isomaltoside 1000 (Monofer(R)) compared with iron sucrose (Venofer(R)) as maintenance therapy in haemodialysis patients.
    Nephrol Dial Transplant. 2015;30:1577-89.
    PubMed     Text format     Abstract available


    August 2015
  11. AIRY M, Mandayam S, Mitani AA, Chang TI, et al
    Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  12. TRAN L, Batech M, Rhee CM, Streja E, et al
    Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  13. EVANS M, Suttorp MM, Bellocco R, Hoekstra T, et al
    Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  14. BESARAB A, Provenzano R, Hertel J, Zabaneh R, et al
    Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


    July 2015
  15. DERAD I, Obermann B, Katalinic A, Eisemann N, et al
    Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  16. FISHBANE SN, Singh AK, Cournoyer SH, Jindal KK, et al
    Ferric pyrophosphate citrate (Triferic) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


  17. NAKANISHI T, Hasuike Y, Nanami M, Yahiro M, et al
    Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited.
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


    June 2015
  18. SUYAMA K, Kawasaki Y, Miyazaki K, Kanno S, et al
    The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Nephrol Dial Transplant. 2015;30:969-77.
    PubMed     Text format     Abstract available


    March 2015
  19. CHEN TK, Estrella MM, Astor BC, Greene T, et al
    Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).
    Nephrol Dial Transplant. 2015.
    PubMed     Text format     Abstract available


    February 2015
  20. GAWEDA AE, Ginzburg YZ, Chait Y, Germain MJ, et al
    Iron dosing in kidney disease: inconsistency of evidence and clinical practice.
    Nephrol Dial Transplant. 2015;30:187-96.
    PubMed     Text format     Abstract available


    June 2014
  21. MACDOUGALL IC, Bock AH, Carrera F, Eckardt KU, et al
    FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.
    Nephrol Dial Transplant. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: